Merit Medical Reports Second Quarter 2026 Results And Updates Full-Year 2026 Guidance

$MMSIPress releaseJul 30, 2026, 4:05 PM ETRead the release

Merit Medical reported Q2 revenue of $418.8 million, up 10% year-over-year, with GAAP EPS rising 20% to $0.65, driven by 9% organic constant currency growth and strong U.S. sales. Profitability expanded as GAAP operating margin increased to 14.4% and non-GAAP operating margin rose to 22.6%, though free cash flow declined 14% year-to-date to $76.6 million.

Key figures

Eps: 0.65
Revenue: $418.8 million
Guidance: FY2026 Revenue $1.631B - $1.643B (raised from $1.612B - $1.634B); Non-GAAP EPS $4.25 - $4.35 (raised from $4.01 - $4.15)
Revenue Yoy: 10%
Non gaap eps: 1.19
Non gaap eps yoy: 18%
Free cash flow ytd: $76.6 million
Gaap operating margin: 14.4%
Operating cash flow ytd: $110.0 million
Non gaap operating margin: 22.6%
Organic constant currency growth: 9%

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.